Structure of Minaprine 2HCl
CAS No.: 25953-17-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Minaprine 2HCl is a reversible inhibitor of MAO-A, also weakly inhibits acetylcholinesterase and is an antidepressant for treatment of depression.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 25953-17-7 |
Formula : | C17H24Cl2N4O |
M.W : | 371.30 |
SMILES Code : | [H]Cl.CC1=CC(C2=CC=CC=C2)=NN=C1NCCN3CCOCC3.[H]Cl |
MDL No. : | MFCD00083410 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H332-H335 |
Precautionary Statements: | P261-P280-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00940823 | - | Completed | - | - | |
NCT03499964 | Urethral Stricture | Not Applicable | Recruiting | November 2024 | United States, Arkansas ... More >> Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Katie O'Brien Principal Investigator: Richard D'Anna, MD Sub-Investigator: Keith Mooney, MD Sub-Investigator: Edwin Diaz, MD Sub-Investigator: Jeffrey Marotte, MD Sub-Investigator: Megan Thomas, APRN United States, Colorado Urology Associates, P.C. Recruiting Englewood, Colorado, United States, 80113 Contact: Lenden Neeper Contact: Michelle Lexin Principal Investigator: Barrett Cowan, MD United States, Florida Advanced Urology Institute Recruiting Daytona Beach, Florida, United States, 32114 Contact: Jonelle Horsley Principal Investigator: Jeffrey Dann, MD United States, Maryland Chesapeake Urology Recruiting Hanover, Maryland, United States, 21076 Contact: Wendy Paxton Principal Investigator: Kaiser Robertson, MD Sub-Investigator: Robert Goldfarb, MD Chesapeake Urology Research Recruiting Towson, Maryland, United States, 21204 Contact: Jacqueline Burmer Principal Investigator: Richard Levin, MD Sub-Investigator: Ronald Tutrone, MD United States, Minnesota University of Minnesota Department of Urology Not yet recruiting Minneapolis, Minnesota, United States, 55445 Contact: Bethany Marlette Principal Investigator: Sean Elliott, MD United States, New Jersey Delaware Valley Urology Recruiting Voorhees, New Jersey, United States, 08043 Contact: Brianna Florentine Principal Investigator: David Sussman, DO United States, New York Western New York Urology Associates Recruiting Cheektowaga, New York, United States, 14225 Contact: Margaret Scott Contact: Thomasina Smith Principal Investigator: Kent Chevli, MD Sub-Investigator: Peter Walter, MD Columbia University Medical Center/New York-Presbyterian Hospital Not yet recruiting New York, New York, United States, 10032 Contact: Debduth Pijush Principal Investigator: Steven Brandes, MD Iris Cantor Men's Health Center Recruiting New York, New York, United States, 10065 Contact: Dominique Thomas Principal Investigator: Alexis Te, MD United States, Oregon Oregon Urology Institute Recruiting Springfield, Oregon, United States, 97477 Contact: Danna Cardenas Principal Investigator: David DiMarco, MD Sub-Investigator: Brian Mehlaff, MD United States, South Carolina Carolina Urology Partners Recruiting West Columbia, South Carolina, United States, 29169 Contact: Pam Tims Contact: Kristin Kennedy Principal Investigator: Brian Willard, MD Sub-Investigator: David Lamb, MD Sub-Investigator: Keith Brightbill, MD Sub-Investigator: Griffin Morrisson, MD United States, Texas Urology San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jeannette Cruz Principal Investigator: Christopher Cantrill, MD Sub-Investigator: Daniel Saltzstein, MD Sub-Investigator: Clayton Hudnall, MD Sub-Investigator: Davie Talley, MD United States, Virginia Urology of Virginia Recruiting Virginia Beach, Virginia, United States, 23462 Contact: Daniel Bekong Principal Investigator: Ramon Virasoro, MD Sub-Investigator: Jessica DeLong, MD Sub-Investigator: Jeremy Tonkin, MD Sub-Investigator: Kurt McCammon, MD United States, Washington University of Washington Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Michael Donahue Principal Investigator: Judith Hagedorn, MD Sub-Investigator: Neils Johnsen, MD Less << |
NCT00852852 | Cancer | Not Applicable | Completed | - | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98115 Less << |
NCT00940823 | Glaucoma | Not Applicable | Completed | - | United States, Indiana ... More >> Eugene and Marilyn Glick Eye Institute Indianapolis, Indiana, United States, 46202 United States, Tennessee Vanderbilt Eye Institute Nashville, Tennessee, United States, 37232 United States, Wisconsin Drs. Massaro and Kalenak Milwaukee, Wisconsin, United States, 53226 Canada, Ontario Credit ValleyEC Toronto, Ontario, Canada, L5L 1W8 Canada, Quebec Montreal Glaucoma Institute Montreal, Quebec, Canada, H1V 1G5 Chile Clinic of Las Condes Santiago, Chile Less << |
NCT02457468 | - | Recruiting | June 2023 | - | |
NCT03265210 | Chronic Pain ... More >>Depression Less << | Not Applicable | Recruiting | September 1, 2019 | United States, New York ... More >> Weill Cornell Internal Medicine Associates Recruiting New York, New York, United States, 10021 Contact: Joanna Pantelides 914-682-9100 ext 2903 jop2285@med.cornell.edu Iris Cantor Men's & Women's Health Centers Recruiting New York, New York, United States, 10065 Contact: Joanna Pantelides 914-682-9100 ext 2903 jop2285@med.cornell.edu Less << |
NCT02522611 | Intractable Pain ... More >> Palliative Care Neoplasm Metastasis Questionnaires &Amp; Surveys Less << | Phase 1 Phase 2 | Recruiting | February 1, 2019 | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov Less << |
NCT00692653 | Prostate Cancer | Not Applicable | Completed | - | United States, Georgia ... More >> VA Medical Center / Medical College of Georgia Augusta, Georgia, United States, 30904 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas University of Texas Health Sciences Center at San Antonio San Antonio, Texas, United States, 78229 United States, Washington Seattle Prostate Institute Seattle, Washington, United States, 98104 Veterans Administration Puget Sound Health Care System Seattle, Washington, United States, 98108 University of Washington Medical Center Seattle, Washington, United States, 98195 Less << |
NCT00345046 | Glaucoma Cata... More >>ract Less << | Phase 4 | Completed | - | United States, Indiana ... More >> IU Eye at Carmel Indianapolis, Indiana, United States, 46290 Less << |
NCT00345046 | - | Completed | - | - | |
NCT00352807 | Cataract | Not Applicable | Completed | - | United States, Indiana ... More >> University Hospital Indianapolis, Indiana, United States, 46202 Veterans Affairs Medical Center Indianapolis, Indiana, United States, 46202 Wishard Memorial Hospital Indianapolis, Indiana, United States, 46202 Iu Eye at Carmel Indianapolis, Indiana, United States, 46290 Less << |
NCT00355446 | Cataract | Phase 4 | Completed | - | United States, Indiana ... More >> University Hospital Indianapolis, Indiana, United States, 46202 Veterans Affairs Medical Center Indianapolis, Indiana, United States, 46202 Wishard Memorial Hospital Indianapolis, Indiana, United States, 46202 IU Eye at Carmel Indianapolis, Indiana, United States, 46290 Less << |
NCT00603304 | Urological | Phase 3 | Completed | - | United States, California ... More >> Kaiser Permanente Division of Research Oakland, California, United States, 94612 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York New York University New York, New York, United States, 10006 Cornell University New York, New York, United States, 10021 United States, Texas University of Texas - Southwestern Medical Center Dallas, Texas, United States, 21201 Canada, Ontario Queen's University Kingston, Ontario, Canada, K7L2V7 Less << |
NCT00392275 | Cataract | Phase 4 | Completed | - | United States, Indiana ... More >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Richard L Rodeboush VA Medical Center Indianapolis, Indiana, United States, 46202 Wishard Memorial Hospital Indianapolis, Indiana, United States, 46202 Less << |
NCT00603304 | - | Completed | - | - | |
NCT00164190 | Myocardial Infarction | Not Applicable | Completed | - | Canada, Ontario ... More >> Southlake Regional Health Centre Newmarket, Ontario, Canada, L3Y 2R2 Less << |
NCT00597181 | Glaucoma | Phase 4 | Terminated(Patient population ... More >>limited) Less << | - | United States, Indiana ... More >> IU Eye at Carmel Indianapolis, Indiana, United States, 46290 Less << |
NCT01142583 | - | Completed | - | - | |
NCT00346489 | Glaucoma | Phase 4 | Completed | - | United States, Indiana ... More >> University Hospital and Outpatient Center Indianapolis, Indiana, United States, 46202 IU Eye at Carmel Indianapolis, Indiana, United States, 46290 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.47mL 2.69mL 1.35mL |
26.93mL 5.39mL 2.69mL |
|
Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
Tags: Minaprine 2HCl | Minaprine dihydrochloride | Morpholines | MAO | Neuronal Signaling | Heterocyclic Building Blocks | 25953-17-7
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL